Answers are grounded in this paper and cite their sources.
Emerging evidence supporting the use of valaciclovir to reduce fetal infection after maternal primary cytomegalovirus (CMV) infection has stimulated interest in routine CMV serological screening in pregnancy. It is important to understand the healthcare consumer perspective of a CMV infection during pregnancy to minimize unintended harms of screening.
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: